Profusa, Inc. (PFSA): Nasdaq/NYSE listing notice — Profusa receives Nasdaq MVLS and bid price deficiency notices; 180-day cure period

Profusa, Inc.

Nasdaq notified Profusa on Sep 11, 2025, that MVLS was below $50M threshold from Jul 29 to Sep 10.
Separate bid price notice for failing to maintain $1.00 minimum closing bid over same period.
Company has until March 10, 2026 to regain compliance; stock continues trading under symbol PFSA.
Compliance requires MVLS >= $50M and bid price >= $1.00 for at least 10 consecutive business days.
If not cured, Profusa may face delisting or could apply to transfer to Nasdaq Capital Market.

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Profusa, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(A), 5810(c)(3)(C)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: market value
Rules: 5450(b)(2)(A), 5810(c)(3)(C)

Exact text from the filing

September 11, 2025, Profusa, Inc. (the “ Company ”) received a notice (the “ MVLS Notice ”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that, based upon its review of the market value of listed securities (“ MVLS ”) of the Company’s common stock, par value $0.0001 per share (the “ Common Stock ”), from July 29, 2025 to September 10, 2025, the Company no longer meets Nasdaq Listing Rule 5450(b)(2)(A), which requires companies listed on the Nasdaq Global Market to maintain a minimum MVLS of $50,000,000. Pursuant to Nasdaq Listing R

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Profusa, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-25-088253

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.